Sale!

ERLIN1 Gene SPG62 ERLIN1 Related Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ERLIN1 gene, associated with SPG62 (a form of hereditary spastic paraplegia), plays a crucial role in the development and function of the nervous system. Mutations in this gene can lead to a range of neurological symptoms, primarily affecting mobility and muscle control. To diagnose this condition, a genetic test targeting the ERLIN1 gene can be conducted.

This specific test, available at DNA Labs UAE, is designed to identify mutations in the ERLIN1 gene that are linked to SPG62. By analyzing a patient’s DNA sample, the test can provide essential information for diagnosis, allowing for a better understanding of the condition and aiding in the development of a targeted treatment plan.

The cost of the ERLIN1 related genetic test at DNA Labs UAE is 4400 AED. This price includes the comprehensive analysis required to detect any genetic abnormalities associated with the ERLIN1 gene. Given the complexity and the specialized nature of this genetic test, the cost reflects the advanced technology and expertise required to accurately identify mutations in the ERLIN1 gene and provide patients with critical information about their condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ERLIN1 Gene SPG62 ERLIN1 related Genetic Test

Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test type: Neurological Disorders
  • Doctor: Neurologist
  • Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for ERLIN1 Gene SPG62, ERLIN1 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ERLIN1 Gene SPG62, ERLIN1 related.

Test Details

The ERLIN1 gene is associated with a rare genetic disorder called spastic paraplegia type 62 (SPG62). SPG62 is characterized by progressive stiffness and weakness in the legs, leading to difficulty walking and sometimes additional symptoms such as intellectual disability and seizures. To diagnose SPG62, a next-generation sequencing (NGS) genetic test can be performed. This test involves sequencing the DNA of the individual to identify any mutations or variations in the ERLIN1 gene that may be causing the disorder. NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of the genetic makeup.

NGS genetic testing for ERLIN1-related SPG62 can help confirm a diagnosis, guide treatment decisions, and provide information for genetic counseling. It can also be useful for identifying carriers of the gene mutation within families and providing prenatal or preimplantation genetic testing options for at-risk individuals. It is important to consult with a healthcare professional or genetic counselor to determine if NGS genetic testing for ERLIN1-related SPG62 is appropriate and to discuss the potential benefits, limitations, and implications of the test.

Test Name ERLIN1 Gene SPG62 ERLIN1 related Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ERLIN1 Gene SPG62, ERLIN1 related NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ERLIN1 Gene SPG62, ERLIN1 related
Test Details

The ERLIN1 gene is associated with a rare genetic disorder called spastic paraplegia type 62 (SPG62). SPG62 is characterized by progressive stiffness and weakness in the legs, leading to difficulty walking and sometimes additional symptoms such as intellectual disability and seizures.

To diagnose SPG62, a next-generation sequencing (NGS) genetic test can be performed. This test involves sequencing the DNA of the individual to identify any mutations or variations in the ERLIN1 gene that may be causing the disorder. NGS technology allows for the analysis of multiple genes simultaneously, providing a comprehensive assessment of the genetic makeup.

NGS genetic testing for ERLIN1-related SPG62 can help confirm a diagnosis, guide treatment decisions, and provide information for genetic counseling. It can also be useful for identifying carriers of the gene mutation within families and providing prenatal or preimplantation genetic testing options for at-risk individuals.

It is important to consult with a healthcare professional or genetic counselor to determine if NGS genetic testing for ERLIN1-related SPG62 is appropriate and to discuss the potential benefits, limitations, and implications of the test.